BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
- Thursday, October 10, 2019, 7:18
- PR Newswire
- Add a comment
LYNBROOK, N.Y., Oct. 10, 2019 /PRNewswire/ — BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in…
About the Author
admin has written 21803 stories on this site.